Shaking up value-based health care: how and why it can work in Australia

[vc_row][vc_column][vc_column_text]In launching its Australian Centre for Value-Based Health Care and two issues briefs which explore definitions and funding options, the AHHA highlights work being undertaken by its members and partners as they seek to maximise value in health care and build on work being led by Commonwealth, state and territory governments to move the focus in health policy from volume to value.

Health systems around the world have been exploring how to move the focus of their activities from delivering volume to delivering value. In doing so, they are trying to re-orient health service delivery to provide improved patient outcomes, often while reducing the overall cost of delivery.

To lay the foundation for what value-based health care means in Australia, the Centre’s first paper considers Australia’s alignment with a value-based approach and identifies important enablers that must be part of a coordinated national strategy.

To enable value-based health care through public policy in Australia, Value based health care: setting the scene for Australia by AHHA Policy Director Kylie Woolcock recommends a national, cross-sector strategy for value-based health care in Australia supported by: access to relevant and up-to-date data; evidence for value-based health care in the Australian context; a health workforce strategy supporting models of care that embrace a value-based approach; and funding systems that incentivise value.

Team-based care models with professionals working at the top of their licence may offer more effective, timelier and better value care than traditional care systems.

Funding arrangements need to move away from a reliance on traditional fee-for-service models, which can entrench fragmented care. Rewards and funding should be re-oriented to what matters to patients, namely health outcomes and ongoing effective management of chronic conditions.

Re-orienting funding from volume to value in public dental health services by Dental Health Services Victoria’s Dr Shalika Hegde outlines how they became the first organisation in Australia to implement a patient-centric, and outcomes and prevention focused value-based health care model in the public dental sector using existing funding.

“Dr Hegde argues for strong national leadership and the cooperation of all jurisdictions to implement a national public dental funding system focused on value and outcomes—which will benefit all parties,” said Ms Verhoeven,

“This is not about saving money—this is about achieving better outcomes that matter to patients and getting better value for every public dollar spent.

“We invite innovative organisations from around Australia to partner with us to go on the value-based health care journey.”

Visit the Australian Centre for Value-Based Health Care at www.valuebasedcareaustralia.com.au. To find out more about the AHHA, visit www.ahha.asn.au.

The Australian Centre for Value-Based Health Care is the nexus of the value-based health care movement in Australia, bringing together educational and training opportunities, quality research and best practice case studies into a hub where those interested in value-based health care can easily find resources.[/vc_column_text][vc_zigzag][/vc_column][/vc_row][vc_row][vc_column width=”1/4″][vc_single_image image=”1850″ img_size=”full”][/vc_column][vc_column width=”3/4″][vc_column_text]You may also be interested in reading:

VALUE-BASED HEALTHCARE IN AUSTRALIA
by Andrew Wiltshire

[/vc_column_text][/vc_column][/vc_row]

Health insurers called out by APRA

[vc_row][vc_column][vc_column_text]In an unprecedented move for the prudential regulator, APRA has called out the industry for being too reliant on lobbying government to provide solutions and underprepared for the challenges that lie ahead.

According to APRA Senior Manager Peter Kohlhagen in a speech to the Health Insurance Summit in Sydney last week, “we aren’t convinced that any insurer yet has a robust strategy for managing the risks”, and that “the current environment is likely to lead to consolidation if it continues for an extended period.”

Mr Kohlhagen emphasized that insurers will need to have a “Plan B” in the event of failure, and that for many that “Plan B” would most likely be a merger.

He also said that “APRA will not hesitate to act to protect the interests of policyholders should it become necessary due to viability concerns with an insurer.”

“That can take the form of an orderly merger or other exit from the market. Importantly, an insurer that has a plan and executes it when it becomes necessary can control its own destiny. An insurer that fails to plan will find that it loses that opportunity.”

With 82 per cent of Australian households concerned about the cost of private health insurance, the rising costs of healthcare and the confusion brought on by the Government’s recent gold/silver/bronze/basic reforms, the risks facing the industry are very real.

APRA’s letters points to active measures that could be taken by health funds to improve industry practices and boost sustainability, such as facilitating substitutes for in-hospital treatment, revising health supplier contracts and developing preventative health and well-being offerings for their members.[/vc_column_text][/vc_column][/vc_row]

Australia’s Health System Explained

[vc_row][vc_column][vc_column_text]The World Health Organization describes a good health system as one that ‘delivers quality services to all people, when and where they need them’. In Australia, our health system is best descried as a complex mix of health professionals and service providers from a range of organisations, including government and non-government sectors, working to meet the health care needs of all Australians.

Australia’s health system has multiple components – health promotion, primary health care, specialist services and hospitals. To meet individual health care needs, a person may need – or have to engage with – the services of more than one part of the system.

1. Primary health care

Primary health care is often a person’s first contact with the health system. It comprises a range of services that are not referred: general practice, allied health services, pharmacy and community health. Various health professionals deliver these, including GPs, nurses, allied health professionals, community pharmacists, dentists and ATSI health workers.

2. Specialist services

Specialist services support people with specific or complex health conditions and issues, such as antenatal services for pregnancy, radiotherapy treatment for cancer and mental health services. Specialist services are generally referred by primary health care providers and often described as ‘secondary’ health care services.

3. Hospitals

Hospitals are a crucial part of Australia’s health system, delivering a range of services to admitted and non-admitted patients (outpatient clinics and emergency department care). All public hospitals in Australia are part of a Local Hospital Network.

State and territory governments largely own and manage public hospitals – which usually provide ‘acute care’ for short periods. Private hospitals are mainly owned and operated by either for-profit or not-for-profit organisations.

Australia’s health system may be more accurately described as various connected health systems, rather than one unified system. The Australian Government, state and territory governments and local governments share responsibility for it, including for its operation, management and funding. While the overarching framework for the health system is laid out by government, the private sector also operates and funds some health services. These including operating private hospitals, pharmacies and many medical practices, as well as funding through private health insurance.

Changes to Australia’s Constitution in 1946 allowed the Federal Government to become involved in the funding of public hospital services, resulting in the funding, operational and regulatory arrangements that exist today.

Australia’s health system is underpinned by Medicare – a universal public health insurance scheme. Medicare is funded by the Australian Government through general taxation revenue and a 2% Medicare levy. Intergovernmental arrangements for public hospital funding between the Australian Government and state and territory governments guarantee Medicare cardholders access to fee-free treatment as public patients in public hospitals. Medicare also covers a portion of the Medicare Benefits Schedule fee for medical services and procedures, and Medicare cardholders have access to a range of prescription pharmaceutical subsidies under the Pharmaceutical Benefits Scheme.

Some medical and allied health services are not subsidised through Medicare. For example, Medicare does not usually cover costs for ambulance services, most dental examinations and treatments, physiotherapy and optical aids (such as glasses and contact lenses).

Private health insurance is also an option for meeting health care expenses in Australia. People can choose the type of cover to buy. The two types of cover available are:

  • Hospital cover for some (or all) of the costs of hospital treatments as a private patient;
  • General treatment (‘ancillary’ or ‘extras’) cover for some non-medical health services not covered by Medicare – such as dental, physiotherapy and optical services.

Private health insurance works in tandem with the publicly funded system but does not cover the entirety of a private patient’s costs. Part of the cost of hospital admission as a private patient is covered by Medicare (the medical fee) and part can be covered by insurance.

The Australian Government and state and territory governments are responsible for the regulation of the health system. Various regulatory agencies within the system work to ensure that acceptable standards and quality of care and services are met, and that people are protected when using health goods and services and when dealing with health professionals.

The Australian Government is also responsible for regulating the safety and quality of pharmaceutical and therapeutic goods and appliances. The Therapeutic Goods Administration (TGA) is responsible for regulating therapeutic goods, including prescription medicines, vaccines, sunscreens, vitamins and minerals, and medical devices.

The Australian Government is also responsible for the Prostheses List. The Prostheses List is a list of medical devices that private health insurers are required to pay a benefit for when one of their members has the relevant coverage. For instance, if a member of a health fund has hospital orthopaedic cover and requires a hip replacement, their health fund is required to pay the minimum benefit for any artificial hip listed on the Prostheses List, with generally no out-of-pocket expenses for the patient.

This arrangement ensures surgeons can choose the best available medical device for their privately insured patients without private health insurers restricting their options.

The List is an essential part of the private health insurance offering, enabling Australians with private health insurance to receive the best quality heal care as determined by their doctor, and not by their health insurance provider.

While Australia’s health care system may indeed seem complex and confusing, it is still one of the best health care systems in the world.[/vc_column_text][vc_column_text]

Information in this article has been informed by the Australian Institute of Health and Welfare report, 'Australia's Health 2018'.

[/vc_column_text][/vc_column][/vc_row]

New Zealand MedTech To Be Impacted

[vc_row][vc_column][vc_column_text]The Government is introducing a new regulatory scheme for therapeutic products, and in addition, PHARMAC, the medicines purchasing agency, is extending its authority over medical devices in public (District Health Board – DHB) hospitals.

A draft bill setting out the framework for the new regulatory regime was released for consultation earlier in the year.  The purpose of the proposed Bill is to:

1. a) ensure acceptable safety, quality, and efficacy or performance of therapeutic products across their lifecycle; and

(b) regulate the manufacture, import, promotion, supply, and administration or use of therapeutic products.

Following the consultation process, a Bill is proposed for introduction into Parliament by the end of 2019 and scheduled for commencement from late 2022.

In addition to these regulatory changes, funding arrangements for devices are also changing -presenting a number of challenges to those operating in New Zealand.

PHARMAC was created in 1993 to manage government spending on medicines. Whilst there is a lot of debate around its impact on the health budget and patient access to innovative medicines, it is undeniable that it has delivered lower spending growth on pharmaceuticals.

New Zealand now has one of the lowest public spends on pharmaceuticals in the OECD. But New Zealand also ranked lowest in the OECD for the proportion of new medicines that are subsidised (2010-2015) – 12% compared with 48% for Australia, and 58% for the OECD on average.  And in 2013, generics accounted for more than three-quarters of the volume of pharmaceuticals in New Zealand.

Since 2012, PHARMAC has been working on the procurement of hospital medical devices including introducing the first national contracts for devices in 2014 and implementing the first market share procurement for wound care in 2017/18.  They now have $200 million under contract.

PHARMAC wants to commence the next phase of its work on medical devices as early as 2020. This would see PHARMAC deciding which medical devices are funded and also making decisions about introducing new technology that DHB hospitals can use.

The conflation of these two changes have significant implications for the 240 companies operating in the medical devices sector in New Zealand. The PHARMAC approach will potentially erode patient and clinician choice, training and education for medical professionals, long term competition and viability of the sector, timely access to innovative therapies, value in healthcare and overall patient outcomes.

The PHARMAC proposal is open for consultation until 28 June 2019.[/vc_column_text][/vc_column][/vc_row]

Labor’s New Shadow Minister for Health Chris Bowen

[vc_row][vc_column][vc_column_text]Christopher Eyles Guy Bowen was born in Sydney and educated at Smithfield Public School and St Johns Park High School in New South Wales. Bowen attended the University of Sydney where he graduated with a Bachelor of Economics, later completing a Masters of International Relations from Griffith University and a Diploma in Modern Languages (Bahasa Indonesia) from the University of New England.

At the age of 22, Bowen worked as a research and media officer to the then Member for Prospect, Janice Crosio MBE, before joining the Finance Sector Union as an industrial from 1995-2000. In 2001 Bowen took up an offer to join the staff of NSW Minister for Roads, Housing and Leader of the House, Patrick Carl Scully as first a Senior Advisor and later as Chief of Staff.

Bowen first started his career in public life when he was elected to Fairfield Council in 1995, and subsequently as mayor from 1998-1999. Between 1999-2001, Bowen went on to become the President of the Western Sydney Regional Organisation of Councils.

In 2004, Bowen stood and was elected for the Federal seat of McMahon to replace his former boss, Janice Crosio, who retired after 25 years in politics.

In 2006, Bowen was appointed to Labor’s frontbench by then Opposition Leader, Kevin Rudd, as Shadow Assistant Treasurer and Shadow Minister for Revenue and Competition Policy.

During the Rudd-Gillard government, Bowen held a wide range of ministerial portfolios, including:

  • Minister for Human Services (2009-2010);
  • Minister for Immigration and Citizenship (2010-2013);
  • Minister for Tertiary Education, Skills, Science and Research (2013); and
  • Minister for Small Business (2013).

After the Labor Government’s 2013 election defeat, Bowen served as interim Labor Leader and Acting Leader of the Opposition during the Labor leadership elections. Following the election of Bill Shorten as Labor Leader and Leader of the Opposition, Bowen was appointed Shadow Treasurer – a position he was well prepared for given his many years working in treasury portfolios.

During his time as Labor’s treasury spokesman, Bowen noted his areas of policy interest included wealth creation, housing affordability and protection of Medicare and of penalty rates. He was also the Opposition’s most vocal advocate for a Royal Commission into banking.

In the lead up to the 2019 Federal Election, many believed that Bowen was Australia’s next Treasurer-in-waiting. However, this was not to be, following Prime Minister Scott Morrison historic election upset that saw the Coalition form a majority government, and reduce Labor’s numbers in the House of Representatives.

In June 2019, after Anthony Albanese was appointed Labor Leader, uncontested, Bowen was moved from the shadow treasury portfolio to the shadow health portfolio, replacing well known health advocate Catherine King.

Upon appointment Bowen released a statement outlining his biggest focuses for the portfolio area, including:

  • Tackling the scourge of diabetes, obesity and the other health challenges in areas of low income and poor health outcomes;
  • Closing the Gap of Indigenous disadvantage in health;
  • Maintaining a passionate interest in mental health and suicide prevention; and
  • Ensuring Medicare is protected and grown.

The statement also reflected that, as the longest serving Shadow Treasurer in Australian history, it was time to hand over the portfolio. Bowen also used the opportunity to acknowledge the work of Catherine King, noting her six years advocating for a better healthcare system for all Australians.

The health sector has welcomed Bowen’s appointment, citing his extensive previous experience and his ability for pragmatic and forward thinking. The Consumer Health Forum released a statement outlining that Bowen brings an impressive record to his new portfolio.

Consumer Health Forum CEO, Leanne Wells, said it was “encouraging to see that he (Bowen) has wasted no time setting out his key priorities, including countering obesity, mental illness and close the gap of indigenous health disadvantage”.

Any industry hopes of a bi-partisan approach to health may have already been dashed. Following Bowen’s appointment to the health portfolio, Minister for Health, Greg Hunt, said in a Tweet: “ Congratulations to Chris Bowen as Labor Health Spokesperson – however, he’s the man who forgot to allocate any funding for a hospital’s agreement despite pledging to do so for 6 years – big promises – zero dollars when it counted.”

The next three years will be critical for the Australian health landscape, with many in the industry wanting a clear and concise policy agenda to be set, so as to sure up investment and funding. The next three years will be one of keen interest and industry engagement for both Greg Hunt and Chris Bowen, as they attempt to make inroads to tackle the most pressing issues facing the sector.[/vc_column_text][/vc_column][/vc_row]

Australia to Order Highest Recorded Number of Flu Vaccines

[vc_row][vc_column][vc_column_text]With many experts stating this is the worst year seen and already equal numbers of recorded diagnoses this year as the entire of 2018.

Minister for Health Greg Hunt reinforced the message that his department will continue to support evidence-based public health initiatives such as vaccination, which he described as ‘the most effective way to protect individuals and the broader community from the flu’.[/vc_column_text][/vc_column][/vc_row]

MedTech The Key for Potential Elimination of HIV in NSW

[vc_row][vc_column][vc_column_text]Due to the increase in HIV testing, the NSW Health HIV Strategy Data Report shows in 2018, NSW had the lowest annual number of notifications on record.

Dr. Kerry Chant, Chief Health Officer stated it is vital that people at risk use the technological resources available, such as increased testing facilities and clinical trialed drugs such as Pre-Exposure Prophylaxis (PrEP).

NSW Health is running HIV testing week from 1 – 7 of June.[/vc_column_text][/vc_column][/vc_row]

Greg Hunt Announces First Two Programs in His Signature Digital Mental Health Plan

[vc_row][vc_column][vc_column_text]The projects funded under this initiative include a specific focus on using digital solutions to prevent the onset of eating disorders, and on transforming our health system to enable earlier intervention so that individuals have the best chance of recovery.

The two projects are:

  • Leveraging digital technology to reduce the prevalence and severity of eating disorders in Australia ($1.34 Million)
  • Detection and intervention system-focused knowledge to drive better outcomes in mainstream care for eating disorders ($3.67 Million)

[/vc_column_text][/vc_column][/vc_row]

Live Streaming to Assist in Young-Onset Dementia Diagnoses

[vc_row][vc_column][vc_column_text]Telehealth uses technology to allow patients, who are deemed clinically appropriate, to have video appointments with specialists using their own smartphone, tablet or computer.

Professor Dennis Velakoulis, Director of the Neuropsychiatry unit at The Royal Melbourne Hospital said on average, people with YOD experience delay in diagnosis of up to 5 years, and have frequently seen numerous medical specialists prior to getting a referral.

“Timely diagnosis is critical to ensure early intervention, adequate treatment and the ability to plan for the future,” Prof Dennis Velkaoulis said.

In 2013 the Department of Health and Human Services established a new Telehealth Unit to drive the uptake of telehealth in Victorian public health services. Stating the practice when appropriate can be a  a cost-effective, real-time and convenient alternative to the more traditional face-to-face way of providing healthcare, professional advice, and education.

With the ability to remove many of the barriers currently experienced by health consumers and professionals, such as distance, time and cost, which can prevent or delay the delivery of timely and appropriate healthcare services and educational support.[/vc_column_text][/vc_column][/vc_row]

mHealth’s Meteoric Rise Needs Careful Watching

[vc_row][vc_column][vc_column_text]These apps range from symptom checkers, self-monitoring, remote monitoring, adherence and rehabilitation facilitators, to the management of clinical and financial records, and health care professional finders. With the potential ability of health apps (known as digital therapeutics) to increase awareness, improve prevention, aid diagnosis and assist in disease management being game-changing.

Although the medical community as a whole generally accepts the use of these apps as part of a broader clinical toolkit, many are slow in their utilisation or recommendation to patients. Many note, with 30-day retention rates of only 59% across all prescribed mHealth apps, the long-term effectiveness is also under scrutiny.[/vc_column_text][/vc_column][/vc_row]